A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
Clinical trial NCT04973605 · RECRUITING
Trial details
- NCT number
- NCT04973605
- Sponsor
- BeOne Medicines
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-16
- Primary completion
- 2026-11-01
- Enrollment
- 246
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.